Viread 300mg Tablet
PDF Leaflet Revision Date: 24 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection and chronic hepatitis B.
Dosage (summary)
300 mg once daily for adults and adolescents u2265 12 years and u2265 35 kg.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Avoid with other tenofovir-containing products
- Caution with nephrotoxic drugs
Contraindications
- Hypersensitivity to tenofovir
- Pregnancy and lactation
Common side effects
- Diarrhea
- Nausea
- Dizziness
- Renal insufficiency
Counselling Points
- Monitor for signs of lactic acidosis
- Avoid breastfeeding
- Regular renal function tests recommended
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Risk of renal failure
Important Disclaimer
The Viread 300mg Tablet professional information leaflet below is the property of Aspen Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
